UBS raised the firm’s price target on Delek US to $32 from $30 and keeps a Neutral rating on the shares. Weaker results at marketing, El Dorado and Big Springs are driving negative revisions vs. prior expectations, the analyst tells investors in a research note. The firm expects Supply, marketing and other loss to get worse in 1Q24 vs. 4Q23, also driving negative revisions.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target raised to $30 from $26 at Mizuho
- Delek US Holdings Unveils New Investor Presentation Initiative
- Delek US price target raised to $32 from $30 at BofA
- Delek Logistics Partners, LP and Delek Logistics Finance Corp. Announce Tender Offer for Any and All of their Outstanding 6.75% Senior Notes due 2025
- Delek US price target raised to $21 from $19 at Wells Fargo
